Manganese superoxide dismutase gene polymorphism (V16A) is associated with diabetic retinopathy in Slovene (Caucasians) type 2 diabetes patients

Disease Markers

Volumn 24, Issue 1, 2008, Pages 59-64

  Petrovič, Mojca Globočnik ^a   Cilenšek, Ines ^b   Petrovič, Daniel ^b,c  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

4a b endothelial nitric oxide synthase polymorphism; Diabetic retinopathy; Genetic markers; Manganese mitochondrial superoxide dismutase V16A polymorphism; Oxidative stress

Indexed keywords

MANGANESE SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DEMOGRAPHY; DIABETIC RETINOPATHY; DISEASE DURATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; SLOVENIA;

EID: 36448962723     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/940703     Document Type: Article

References (36)

1. A.G. Allen and M. Tresini, Oxidative stress and gene regulation, Free Radic Biol Med 28 (2000), 463-499.
2. T. Awata T, T. Neda, H. Iizuka, S. Kurihara, T. Ohkubo, N. Takata, M. Osaki, M. Watanabe, Y. Nakashima, T. Sawa, K. Inukai, I. Inoue, M. Shibuya, K. Mori, S. Yoneya and S. Katayama, Endothelial nitric oxide synthase gene is associated with diabetic macular edema in type 2 diabetes, Diabetes Care 27 (2004), 2184-2190.
3. S. Beatty, H. Koh, M. Phil, D. Henson and M. Boulton, The role of oxidative stress in the pathogenesis of agerelated macular degeneration, Surv Ophthalmol 45 (2000), 115-134.
4. M. Bergman, M. Ahnstrom, P. Palmback Wegman and S. Wingren, Polymorphism in the manganese superoxide dismutase (MnSOD) gene and risk of breast cancer in young women, J Cancer Res Clin Oncol 131 (2005), 39-44.
5. V.M. Campese, R.K. Sindhu, S. Ye, Y. Bai, N.D. Vaziri and B. Jabbari, Regional expression of NO synthase, NAD(P)H oxidase and superoxide dismutase in the rat brain, Brain Res 1134 (2007), 27-32.
6. D.A. Chistyakov, K.V. Savost'anov, E.V. Zotova and V.V. Nosikov, Polymorphisms in the Mn-SOD and EC-SOD genes and their relationship to diabetic neuropathy in type 1 diabetes mellitus, BMC Med Genet 2 (2001), 4-10.
7. C. Cingolani, B. Rogers, L. Lu, S. Kachi, J. Shen and P.A. Campochiaro, Retinal degeneration from oxidative damage, Free Radical Biol Med 40 (2006), 660-669.
8. M. Colasanti and H. Suzuki, The dual personality of NO, Trends Pharmacol Sci 21 (2000), 249-252.
9. K. Dahl-Jorgensen, O. Brinchmann-Hansen, K.F. Hanssen, L. Sandvik and O. Aagenaes, Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study, Br Med J 290 (1985), 811-815.
10. D.E. DeWitt and I.B. Hirsch, Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review, JAMA 289 (2003), 2254-2264.
11. F. Degoul, A. Sutton, A. Mansouri, C. Cepanec, C. Degott, B. Fromenty, M. Beaugrand and D. Valla, Homozygosity for alanine in the mitochondrial targeting sequence of superoxide dismutase and risk for severe alcoholic liver disease, Gastroenterology 120 (2001), 1468-1474.
12. H. Ding, M. Hashem and C. Triggle, Increased oxidative stress in the streptozotocin-induced diabetic apoE-deficient mouse: Changes in expression ofNADPHoxidase subunits and eNOS, Eur J Pharmacol 561 (2007), 121-128.
13. Y. Du, C.M. Miller and T.S. Kern, Hyperglycemia increases mitochondrial superoxide in retina and retinal cells, 35 Free Radical Biol Med (2003), 1491-1499.
14. Early Treatment Diabetic Retinopathy Study Research Group: Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification ETDRS report number 10, Ophthalmology 98(Suppl 5) (1991), 786-806.
15. S.K. Jain, R. McVie, J. Duett and J.J. Herbst, Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes, Diabetes 38 (1989), 1539-1543.
16. K. Kannan and S.K. Jain, Oxidative stress and apoptosis, Pathophysiology 7 (2000), 153-163.
17. R.A. Kowluru, L. Lamia Atasi and Y.S. Ho, Role of Mitochondrial Superoxide Dismutase in the Development of Diabetic Retinopathy Invest Ophthalmol, Vis Sci 47 (2006), 1594-1599.
18. R.A. Kowluru, Diabetic retinopathy: mitochondrial dysfunction and retinal capillary cell death, Antioxid Redox Signaling 7 (2005), 1581-1587.
19. S.J. Lee and M.G. Choi, Association of manganese superoxide dismutase gene polymorphism (V16A) with diabetic macular edema in Korean type 2 diabetic patients, Metabolism 55 (2006), 1681-1688.
20. H. Li and U. Forstermann, Nitric oxide in the pathogenesis of vascular disease, J Pathol 190 (2000), 244-254.
21. P.A. Marsden, H.H. Heng, S.W. Scherer, R.J. Stewart, A.V. Hall, X.M. Shi, L.C. Tsui and K.T. Schappert, Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene, J Biol Chem 268 (1993), 17478-17488.
22. A. Milutinovic and H. Hruskovicova, The eNOS gene polymorphism does not have a major impact on lipid parameters and premature coronary artery disease in Slovene men (Caucasians), Folia Biol (Praha) 51 (2005), 47-49.
23. S. Neugebauer, T. Baba and T. Watanabe, Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes, Diabetes 49 (2000), 500-503.
24. T. Nomiyama, Y. Tanaka, L. Piao, K. Nagasaka, K. Sakai, T. Ogihara, K. Nakajima, H. Watada and R. Kawamori, The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients, J Hum Genet 48 (2003), 138-141.
25. V. Poulaki, W. Qin, A.M. Joussen, P. Hurlbut, S.J. Wiegand, J. Rudge, G.D. Yancopoulos and A.P. Adamis, Acute inten sive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1 and VEGF, J Clin Invest 109 (2002), 805-815.
26. S. Shimoda-Matsubayashi, H. Matsumine, T. Kobayashi, Y. Nakagawa-Hattori, Y. Shimizu and Y. Mizuno, Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson (http://www.springerlink.com/content/ ku64v3704545x51p/ xlarge8217.gif) isn't in documents disease, Biochem Biophys Res Commun 13 (1996), 561-565.
27. A. Sutton, A. Imbert, A. Igoudjil, V. Descatoire, S. Cazanave, D. Pessayre and F. Degoul, The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability, Pharmacogenet Genomics 15 (2005), 311-319.
28. M.J. Taverna, A. Sola, C. Guyot-Argenton, N. Pacher, F. Bruzzo, A. Chevalier, G. Slama, G. Reach and J.L. Selam, The eNOS4 polymorphism of the endothelial nitric oxide synthase predicts risk for severe diabetic retinopathy, Diabet Med 19 (2002), 240-245.
29. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diabetes Care 20 (1997), 1183-1197.
30. T. Tsukada, K. Yokoyama, T. Arai, F. Takemoto, S. Hara, A. Yamada, Y. Kawaguchi, T. Hosoya and J. Igari, Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans, Biochem Biophys Res Commun 245 (1998), 190-193.
31. L. Valenti, D. Conte, A. Piperno, P. Dongiovanni, A.L. Fracanzani, M. Fraquelli, V. Vergani, C. Gianni, L. Carmagnola and S. Fargion, The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis, J Med Genet 41 (2004), 46-50.
32. N.D. Vaziri, Y.S. YS, C.Y. Lin, V.W. Lin and R.K. Sindhu, NAD(P)H oxidase, superoxide dismutase, catalase, glutathione peroxidase and nitric oxide synthase expression in subacute spinal cord injury, Brain Res (2004), 76-83.
33. X.L. Wang, A.S. Sim, R.F. Badenhop, R.M. McCredie and D.E. Wilcken, A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene, Nature Med 2 (1996), 41-45.
34. I.A. Strokov, T.R. Bursa, O.I. Drepa, E.V. Zotova, V.V. Nosikov and A.S. Ametov, Predisposing genetic factors for diabetic polyneuropathy in patients with type 1 diabetes: a population-based case-control study, Acta Diabetol 40(Suppl 2) (2003), S375-S379.
35. T.M. Davis, I.M. Stratton, C.J. Fox, R.R. Holman and R.C. Turner, U.K. Prospective Diabetes Study 22. Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM, Diabetes Care 20 (1997), 1435-1441.
36. I.M. Stratton, E.M. Kohner, S.J. Aldington, R.C. Turner, R.R. Holman, S.E. Manley and D.R. Matthews, UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis, Diabetologia 44 (2001), 156-163.